- ICH GCP
- Yhdysvaltain kliinisten tutkimusten rekisteri
- Kliininen tutkimus NCT01324648
Evaluation of the Bounce Back Program
A Randomized Controlled Trial Evaluation of Brief, Telephone Supported CBT Self-help in Primary Care Patients With Mild to Moderate Depression
Lifetime prevalence rates of Major Depressive Disorder (MDD) in Canada are between 10-12% with approximately 1.5 million Canadians reporting depression in any given year. Alarmingly, the burden of ill health associated with MDD is projected to increase worldwide such that by the year 2020, depression will move from its current position of fourth to become the second greatest burden of ill health, closely following ischaemic heart disease (Murray & Lopez, 1998). As depressed patients are often in frequent contact with their primary care physicians for other health problems, effective depression treatment and management currently relies heavily on the primary care sector. Cognitive behavioural therapy (CBT) is an empirically supported psychotherapy that is recommended by the Canadian Network for Mood and Anxiety Treatments Clinical Guidelines as a first-line treatment for depression. However, across Canada, CBT is not readily accessible by primary care physicians for their patients, particularly in rural areas.
To help address this nationwide need for CBT, British Columbia (BC) is the first and only province in Canada to develop and implement a high capacity mental health service, Bounce Back: Reclaim your Health (BB), for primary care patients with mild to moderate depression. In BB, the patients' use of Cognitive-Behavioural Therapy (CBT) self-help materials is supported via trained telephone coaches.
The primary objective of our proposed research is to provide direct evidence of the effectiveness of the BB program, and, in particular, the telephone coaching component. The investigators will test: (1) whether the BB program is more effective than general practitioner (GP) treatment-as-usual (TAU); and (2) whether BB's positive results can be attributed to the telephone coaching component, as this component is associated with the most significant costs of the program. A secondary objective is to assess the cost-effectiveness of such telephone support.
Tutkimuksen yleiskatsaus
Tila
Ehdot
Yksityiskohtainen kuvaus
Opintotyyppi
Ilmoittautuminen (Odotettu)
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Opiskelupaikat
-
-
Alberta
-
Calgary, Alberta, Kanada, T3G0B4
- Rekrytointi
- Calgary Foothills Primary Care Network
-
Ottaa yhteyttä:
- Lorraine Bucholtz
- Puhelinnumero: 403-284-3726
- Sähköposti: Lorraine.Bucholtz@cfpcn.ca
-
Ottaa yhteyttä:
- Richard Ward, MD
- Sähköposti: raward@direct.ca
-
Alatutkija:
- Richard Ward, MD
-
Chinook Valley, Alberta, Kanada, T1J013
- Rekrytointi
- Chinook Primary Care Network
-
Ottaa yhteyttä:
- Lisa Cook, PhD
- Sähköposti: lisa.cook@albertahealthservices.ca
-
Ottaa yhteyttä:
- Robert Wedel, MD
- Sähköposti: rwedel@telusplanet.net
-
Päätutkija:
- Robert Wedel, MD
-
-
British Columbia
-
Vancouver, British Columbia, Kanada, V6T2A1
- Ei vielä rekrytointia
- University of British Columbia
-
Päätutkija:
- Mark Lau, PhD
-
-
Osallistumiskriteerit
Kelpoisuusvaatimukset
Opintokelpoiset iät
Hyväksyy terveitä vapaaehtoisia
Sukupuolet, jotka voivat opiskella
Kuvaus
Inclusion Criteria:
- currently experiencing a mild to moderate level of depressive symptoms as defined by a score of 5 - 19 on the PHQ-9;
- 19 years of age or older
- willing to use the BB program;
- able to use the BB self-help materials with telephone coaching (have access to read, hear a telephone conversation and have a telephone); and,
- ability to give informed consent and complete questionnaires unassisted.
Exclusion Criteria:
- a SCID diagnosis (past or present) of: (a) Bipolar Disorder; (b) Schizophreniform Disorders; (c) Substance Abuse or Dependence (current or within the past six months); (d) Borderline or Antisocial Personality Disorder (based on GP's diagnosis); or (e) Cognitive Disorder (as the BB program is not appropriate for these individuals);
- active suicidal intent, (as defined by a score of 2 or more on the BDI-II suicide item #9; those with passive suicidal ideation will be monitored;
- impaired concentration and motivation (scoring 7 or more on the combined BDI-II items #15, 19 and 20 for energy, concentration difficulty and tiredness, respectively);
- are currently receiving, or have received in the previous 6 months, CBT or guided self-help for depression; or,
- are involved in other clinical research studies.
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Hoito
- Jako: Satunnaistettu
- Inventiomalli: Rinnakkaistehtävä
- Naamiointi: Kaksinkertainen
Aseet ja interventiot
Osallistujaryhmä / Arm |
Interventio / Hoito |
---|---|
Kokeellinen: TG + GP TAU
|
Participants' use of the BB self-help materials will be supported by three to five telephone coaching sessions that occur approximately every 2-3 weeks.
Total contact time will be approximately 2 hours (2 hour total contact time will be considered "brief" in our study).
Participants will also continue to receive whatever current treatment their general practitioner is providing.
|
Kokeellinen: UG + GP TAU
|
This treatment was chosen as a control for the telephone coaching component of the BB program.
Participants will be sent a package containing the BB self-help materials and along with instructions on how to utilize these materials.
Participants will use the materials on their own and at their own pace.
Participants will also continue to receive whatever current treatment their general practitioner is providing.
|
Active Comparator: GP TAU
|
This group will receive treatment as usual - whereby the clinic staff will inform the participant's GP of their PHQ-9 score.
They will also be informed that their GP will be contacted that they are taking part in the research and that their GP will continue to support them with their depression as usual.
|
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
---|---|---|
Changes in levels of depressive symptomatology
Aikaikkuna: The PHQ-9 will be assessed at screening, 2 month, 4 month, and 12 month time points.
|
Levels of depressive symptomatology will be measured over time, using the Patient Health Questionnaire (PHQ-9)
|
The PHQ-9 will be assessed at screening, 2 month, 4 month, and 12 month time points.
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
---|---|---|
Changes of levels of anxiety
Aikaikkuna: The GAD-7 will be assessed at baseline, 2 month, 4 month, and 12 month time points
|
Levels of anxiety will be measured over tiem, using the Generalized Anxiety Disorder 7 (GAD-7).
|
The GAD-7 will be assessed at baseline, 2 month, 4 month, and 12 month time points
|
Changes in quality of life and enjoyment
Aikaikkuna: The QLES-Q-SF will be assessed at baseline, 2 month, 4 month, and 12 month time points
|
Quality of life and enjoyment will be measured over time using the Quality of Life and Enjoyment Satisfaction Questionnaire (QLES-Q-SF).
|
The QLES-Q-SF will be assessed at baseline, 2 month, 4 month, and 12 month time points
|
Changes in work and social adjustment
Aikaikkuna: The WASA will be assessed at baseline, 2 month, 4 month, and 12 month time points
|
Work and social adjustemnt will be assessed over time, using the Work and Social Adjustment Scale (WASA).
|
The WASA will be assessed at baseline, 2 month, 4 month, and 12 month time points
|
Changes in work functionality and impairment
Aikaikkuna: The LEAPS will be assessed at baseline, 2 month, 4 month, and 12 month time points
|
Work functionality and impairment will be assessed over time using the Lam Employment and Productivity Scale (LEAPS).
|
The LEAPS will be assessed at baseline, 2 month, 4 month, and 12 month time points
|
Changes in mental health literacy
Aikaikkuna: The MHL-Q will be assessed at baseline, 2 month, 4 month, and 12 month time points
|
Mental health literacy will be measured over time using the Mental Health Literacy questionnaire (MHL-Q).
|
The MHL-Q will be assessed at baseline, 2 month, 4 month, and 12 month time points
|
Changes in use of health services
Aikaikkuna: The CSRI will be asssessed at screening, 4 month, and 12 month time points
|
Participants' use of health services will be assessed using the Client Service Receipt Inventory - modified (CSRI).
|
The CSRI will be asssessed at screening, 4 month, and 12 month time points
|
Changes in health status
Aikaikkuna: The EQ-5D will be assessed at baseline, 2 month, 4 month, and 12 month time points
|
Health status will be assessed using the Euroquol-5 (EQ-5D).
|
The EQ-5D will be assessed at baseline, 2 month, 4 month, and 12 month time points
|
Changes in health status and health related quality of life
Aikaikkuna: The HUI-3 will be assesed at baseline, 2 month, 4 month, and 12 month time points
|
Health status and health related quality of life will be assessed over time using the Health Utilities Index (HUI-3).
|
The HUI-3 will be assesed at baseline, 2 month, 4 month, and 12 month time points
|
Changes in illness severity
Aikaikkuna: The DUSOI will be assessed at baseline, 2 month, 4 month, and 12 month time points
|
Illness severity will be assessed over time using the Duke Severity of Illness Checklist (DUSOI).
|
The DUSOI will be assessed at baseline, 2 month, 4 month, and 12 month time points
|
Client satisfaction.
Aikaikkuna: The CSQ-9 will be assessed at 4 month time point.
|
Client satisfaction will be assessed using the Client Satisfaction Questionnaire 9 (CSQ-9).
|
The CSQ-9 will be assessed at 4 month time point.
|
Yhteistyökumppanit ja tutkijat
Sponsori
Tutkijat
- Päätutkija: Mark Lau, PhD, University of British Columbia
Julkaisuja ja hyödyllisiä linkkejä
Hyödyllisiä linkkejä
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus
Ensisijainen valmistuminen (Odotettu)
Opintojen valmistuminen (Odotettu)
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Arvio)
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Arvio)
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Muita asiaankuuluvia MeSH-ehtoja
Muut tutkimustunnusnumerot
- H08-02847
- 106504 (Muu apuraha/rahoitusnumero: Canadian Institute of Health Research)
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .